Amgen Inc (AMGN)
264.08
-1.60
(-0.60%)
USD |
NASDAQ |
Apr 17, 16:00
264.08
0.00 (0.00%)
After-Hours: 20:00
Amgen Profit Margin (Quarterly): 9.36% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.36% |
| September 30, 2023 | 25.06% |
| June 30, 2023 | 19.74% |
| March 31, 2023 | 46.54% |
| December 31, 2022 | 23.63% |
| September 30, 2022 | 32.22% |
| June 30, 2022 | 19.97% |
| March 31, 2022 | 23.66% |
| December 31, 2021 | 27.74% |
| September 30, 2021 | 28.09% |
| June 30, 2021 | 7.11% |
| March 31, 2021 | 27.89% |
| December 31, 2020 | 24.34% |
| September 30, 2020 | 31.46% |
| June 30, 2020 | 29.05% |
| March 31, 2020 | 29.62% |
| December 31, 2019 | 27.48% |
| September 30, 2019 | 34.30% |
| June 30, 2019 | 37.11% |
| March 31, 2019 | 35.85% |
| December 31, 2018 | 30.95% |
| September 30, 2018 | 31.49% |
| June 30, 2018 | 37.89% |
| March 31, 2018 | 41.61% |
| December 31, 2017 | -73.49% |
| Date | Value |
|---|---|
| September 30, 2017 | 35.01% |
| June 30, 2017 | 37.02% |
| March 31, 2017 | 37.90% |
| December 31, 2016 | 32.44% |
| September 30, 2016 | 34.71% |
| June 30, 2016 | 32.88% |
| March 31, 2016 | 34.38% |
| December 31, 2015 | 32.51% |
| September 30, 2015 | 32.55% |
| June 30, 2015 | 30.78% |
| March 31, 2015 | 32.25% |
| December 31, 2014 | 24.27% |
| September 30, 2014 | 24.73% |
| June 30, 2014 | 29.86% |
| March 31, 2014 | 23.73% |
| December 31, 2013 | 20.38% |
| September 30, 2013 | 28.81% |
| June 30, 2013 | 26.89% |
| March 31, 2013 | 33.84% |
| December 31, 2012 | 17.82% |
| September 30, 2012 | 25.63% |
| June 30, 2012 | 28.28% |
| March 31, 2012 | 29.25% |
| December 31, 2011 | 23.51% |
| September 30, 2011 | 11.51% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
7.11%
Minimum
Jun 2021
46.54%
Maximum
Mar 2023
26.55%
Average
27.74%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences Inc | 20.09% |
| Johnson & Johnson | 18.92% |
| Eli Lilly and Co | 23.41% |
| Merck & Co Inc | -8.38% |
| Vertex Pharmaceuticals Inc | 38.48% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 113.2% |
| Return on Assets | 7.78% |
| Return on Invested Capital | 10.60% |
| Gross Profit Margin (Quarterly) | 62.03% |
| Operating Margin (Quarterly) | 15.51% |
| Return on Net Operating Assets | 12.68% |